Osprey Private Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16M Buy
61,351
+1,345
+2% +$345K 3.88% 6
2026
Q2
$15.1M Buy
60,006
+846
+1% +$182K 3.9% 5
2026
Q1
$12.9M Buy
59,160
+3,360
+6% +$745K 3.73% 5
2025
Q4
$12.7M Buy
55,800
+5,490
+11% +$1.25M 3.67% 7
2025
Q3
$11.6M Buy
50,310
+11,200
+29% +$2.28M 4.23% 6
2025
Q2
$7.4M Buy
39,110
+890
+2% +$165K 4.03% 8
2025
Q1
$8.01M Buy
38,220
+6,575
+21% +$1.28M 4.75% 6
2024
Q4
$5.62M Buy
31,645
+185
+0.6% +$34K 3.93% 8
2024
Q3
$6.21M Buy
+31,460
New +$5.87M 4.35% 5

Other funds holding ABBV

Osprey Private Wealth's ABBV Position: Q3 2026 in Review

Osprey Private Wealth increased its AbbVie (ABBV) stake by 2.2% in Q3 2026, buying an estimated $345K and bringing the position to 61,351 shares worth $16M. The position accounts for 3.88% of the portfolio, ranked #6.

Osprey Private Wealth first reported a position in ABBV in Q3 2024 and has held it in 9 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Osprey Private Wealth held 61,351 shares of AbbVie worth $16M as of Q3 2026.
  • Osprey Private Wealth bought 1,345 AbbVie shares in Q3 2026, an estimated $345K.
  • AbbVie made up 3.88% of Osprey Private Wealth's portfolio in Q3 2026, its #6 holding.
  • Osprey Private Wealth first reported a position in AbbVie in Q3 2024 and has held it in 9 quarters since.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Osprey Private Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.